Xconomy: Genocea Gets UW, Hutch Patents
Genocea Biosciences, a Cambridge, MA-based vaccine developer, said today it has obtained licenses to 25 pending or issued patents on herpes simplex type 2 antigens from the University of Washington and Fred Hutchinson Cancer Research Center.
If you enjoyed this post, make sure you subscribe to my RSS feed!
